Back to News
Market Impact: 0.15
Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
Source: Newswire
Product LaunchesCompany Fundamentals
Dermata said Tome Clearing Treatment will be the second once-weekly skincare product under its Tome brand. The product combines a salicylic acid wipe with the company’s Bioneedle™ mask and is expected to launch in the first half of 2027 for professionals and consumers.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- PC chip plunge wipes out a quarter of Intel’s value
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Daiichi Sankyo’s first-half profit rises on cancer drug growth; shares up